Investors race to cover 'quality' Medacta IPO

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

Investors race to cover 'quality' Medacta IPO

Sam Kerr
March 22, 2019 03:15 pm
alamy_hip_joint_230x150
C55PH7 Artificial hip implants on blue background, studio shot | Alamy Stock Photo

Medacta, a manufacturer of orthopaedic devices, was covered within hours of setting the terms on its Swiss IPO, valuing the company at up to Sfr2.08bn.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

SwitzerlandJP MorganMorgan StanleyCredit SuisseEquity IPOsUBSEquityEuropeEMEASRI
SK
Sam Kerr
Gift this article